Business Context and Reporting Period
This Form 8-K is a current report filed by Second Sight Medical Products, Inc. (trading symbol: EYES) on August 31, 2020. The filing addresses a material change in corporate leadership rather than financial performance for a specific reporting period.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is limited to personnel changes and does not contain financial statements or operational metrics.
Material Changes
- Departure of CFO: John T. Blake, Chief Financial Officer, submitted his resignation effective September 4, 2020, to pursue other opportunities.
- Appointment of Interim Officer: Edward Sedo, previously the Controller, has been appointed as the Principal Accounting and Financial Officer.
- Role Transition: Mr. Sedo will assume the majority of Mr. Blake's duties.
Guidance, Outlook, and Risks
The filing contains no management commentary regarding future guidance, outlook, risks, contingencies, or unusual items. The document is strictly a notification of the executive departure and appointment.
Investor Verification Checklist
- Verify the effective date of the CFO transition (September 4, 2020).
- Confirm the background and qualifications of the new Principal Accounting and Financial Officer, Edward Sedo.
- Review subsequent filings for any impact on financial reporting timelines or internal controls resulting from this leadership change.
- Note the discrepancy between the request metadata ("Vivani Medical, Inc.") and the actual filing registrant ("Second Sight Medical Products, Inc.").